Braslyn Ltd. Mirati Therapeutics, Inc. (MRTX) insider trading activity

Braslyn Ltd. is > 10% Shareholder of Mirati Therapeutics, Inc.. Currently has a direct ownership of 3.14 Million shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 10, 2021, when has been sold 410 shares (Common Stock) at a price of $196.38 per share, resulting in proceeds of $80,516. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.14M

0% 3M change

0% 12M change

Total Value Held $0

Braslyn Ltd. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2021	SELL Open market or private sale	$80,516 $196.38 p/Share	410 Reduced 0.01%	3,135,966 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	-	410 Added 0.01%	3,135,967 Common Stock
Mar 09 2021	SELL Open market or private sale	$2,348,710 $196.2 p/Share	11,971 Reduced 0.38%	3,135,966 Common Stock
Mar 09 2021	BUY Exercise of conversion of derivative security	-	11,971 Added 0.38%	3,135,967 Common Stock
Oct 29 2020	SELL Open market or private sale	$22,194,754 $212.26 p/Share	104,564 Reduced 3.33%	3,031,402 Common Stock
Oct 29 2020	SELL Payment of exercise price or tax liability	$202 $202.25 p/Share	1 Reduced 0.0%	3,135,966 Common Stock
Oct 29 2020	BUY Exercise of conversion of derivative security	-	104,565 Added 3.23%	3,135,967 Common Stock

Oct 28 2020	SELL Open market or private sale	$61,270,472 $207.39 p/Share	295,436 Reduced 9.42%	2,840,530 Common Stock
Oct 28 2020	SELL Payment of exercise price or tax liability	$418 $209.16 p/Share	2 Reduced 0.0%	3,135,966 Common Stock
Oct 28 2020	BUY Exercise of conversion of derivative security	-	295,438 Added 8.61%	3,135,968 Common Stock
Jun 12 2020	SELL Open market or private sale	$41,400,000 $69.0 p/Share	600,000 Reduced 19.13%	2,535,966 Common Stock
Jun 12 2020	SELL Payment of exercise price or tax liability	$436 $72.8 p/Share	6 Reduced 0.0%	3,135,966 Common Stock
Jun 12 2020	BUY Exercise of conversion of derivative security	-	600,006 Added 16.06%	3,135,972 Common Stock
Mar 01 2019	SELL Open market or private sale	$18,975,000 $69.0 p/Share	275,000 Reduced 8.77%	2,860,966 Common Stock
Mar 01 2019	SELL Payment of exercise price or tax liability	$291 $72.8 p/Share	4 Reduced 0.0%	3,135,966 Common Stock
Mar 01 2019	BUY Exercise of conversion of derivative security	-	275,004 Added 8.06%	3,135,970 Common Stock

Also insider at

INSG

INSEEGO CORP. Technology

> 10% Shareholder

Braslyn Ltd.

> 10% Shareholder

Lyford Cay, New Providence, C5

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Mirati Therapeutics, Inc.

Track Activities on MRTX

Account